ORBUS THERAPEUTICS
They at Orbus are committed to bringing innovative products to the extremely underserved patients affected by rare diseases. They are focused and passionate about bringing a more positive outcome to patients facing life-threatening or significantly life-altering diseases. Currently, Orbus Therapeutics is working to develop and commercialize eflornithine in North America. The company was founded in 2012 and is headquartered in Palo Alto, California.
ORBUS THERAPEUTICS
Industry:
Biotechnology Health Care Health Diagnostics Therapeutics
Founded:
2012-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.orbustherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
650-656-9440
Total Funding:
55 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager Content Delivery Network Global Site Tag Typekit Squarespace Squarespace Add To Cart Stocksy
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
BiPlastiq
BiPlastiq is a startup dedicated to developing radical technological advancements.
Carbylan Therapeutics
Carbylan Therapeutics was founded in 2004
i-Optics
i-Optics offers eye diagnosis solutions and products for age related eye diseases.
Odyssey Therapeutics
Odyssey Therapeutics provides medicines to patients with inflammatory diseases and cancer.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
PolyCore Therapeutics
PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Stemline Therapeutics
Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.
Current Advisors List
Board_observer
2015-01-01
Board_member
Board_member
2015-07-01
Board_member
Board_member
Board_member
Board_member
2020-07-01
Current Employees Featured
Jason Levin Chief Operating Officer, Co-Founder, Board member @ Orbus Therapeutics
Chief Operating Officer, Co-Founder, Board member
2012-02-01
Bob Myers CEO & Founder @ Orbus Therapeutics
CEO & Founder
Founder
Investors List
Agent Capital
Agent Capital investment in Series B - Orbus Therapeutics
Adams Street Partners
Adams Street Partners investment in Series A - Orbus Therapeutics
Ernest Mario
Ernest Mario investment in Series A - Orbus Therapeutics
H.I.G. BioHealth Partners
H.I.G. BioHealth Partners investment in Series A - Orbus Therapeutics
Longitude Capital
Longitude Capital investment in Series A - Orbus Therapeutics
Official Site Inspections
http://www.orbustherapeutics.com
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Orbus Therapeutics"
Orbus Therapeutics - Crunchbase Company Profile & Funding
They at Orbus are committed to bringing innovative products to the extremely underserved patients affected by rare diseases. They are focused and passionate about bringing a more …See details»
Leadership — Orbus Therapeutics
Jason Levin Founder, Director and president. Prior to founding Orbus Therapeutics, Jason was Chief Business Officer of Sorbent Therapeutics, Inc., a company focused on the development of oral polymers to treat chronic heart …See details»
Orbus Therapeutics, Inc. | Devex
Learn more about Orbus Therapeutics, Inc.'s jobs, projects, latest news, contact information and geographical presence. Orbus Therapeutics is dedicated to developing products that treat rare ...See details»
Orbus Therapeutics, Inc. Information - RocketReach
Orbus Therapeutics Inc. is a late-stage, private biopharmaceutical company that is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies.See details»
Orbus Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Orbus Therapeutics, Inc. of Palo Alto, CA. Get the latest business insights from Dun & Bradstreet.See details»
Orbus Therapeutics, Inc. | LinkedIn
Orbus Therapeutics, Inc. | 184 followers on LinkedIn. Developing novel therapies for rare, orphan diseases.See details»
Orbus Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Orbus Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 4 news, and 4 literature, Disease Domain:Endocrinology and Metabolic Disease, …See details»
Org Chart Orbus Therapeutics - The Official Board
Organizational Chart of Orbus Therapeutics. Orbus Therapeutics www.orbustherapeutics.com. +1 650 656 9440See details»
Orbus Therapeutics, Inc. Management Team | Org Chart
Orbus Therapeutics, Inc. employs 3 employees. The Orbus Therapeutics, Inc. management team includes Jason Levin (President, Co-Founder, Board member), Noymi Yam (VP, Chief …See details»
Orbus Therapeutics - Overview, News & Similar companies
Jan 18, 2022 Orbus Therapeutics contact info: Phone number: (650) 656-9440 Website: www.orbustherapeutics.com What does Orbus Therapeutics do? Orbus Therapeutics Inc. is a …See details»
About Orbus - Orbus Therapeutics
Brain Cancer clinical trial for Anaplastic Astrocytoma. Since there is a need for better treatment options for patients diagnosed with AA, we are evaluating eflornithine in a clinical study. …See details»
Orbus Therapeutics, Inc.:Company Profile & Technical Research ...
Orbus Therapeutics, Inc. is a company that provides Anaplastic astrocytoma, Medicine, Pharmacy and Therapeutics and more. Orbus Therapeutics, Inc. is headquartered in United States …See details»
Orbus Therapeutics Company Profile -Sales, Contacts, Competitors …
Orbus Therapeutics is in the Pharmaceutical Preparations industry within the Chemicals and Allied Products sector and has been in business for approximately 13 years.See details»
Our team helping patients with brain cancer. - Orbus Therapeutics
Since there is a need for better treatment options for patients diagnosed with AA, we are evaluating eflornithine in a clinical study. Patients with AA who have progressed or recurred …See details»
Orbus Therapeutics - VentureRadar
Similar Companies: PellePharm USA Privately Held PellePharm, Inc.is a biotechnology company which develops skin cancer therapeutics. The company provides oral medications for basal …See details»
Orbus Therapeutics CEO and Key Executive Team | Craft.co
Orbus Therapeutics's Founder, President and Chief Executive Officer, Director is Bob Myers. Other executives include Jason Levin, Founder, Chief Operating Officer, Director; Terry Gould, …See details»
Orbus Therapeutics, Inc. (Orbus Therapeutics, Inc.) - 药物管线_专 …
For more information, please visit the Company's website at Source: Orbus Therapeutics, Inc. Investor Contact: Jason Levin, COO jason.levin@orbustherapeutics.com 650.656.9440 Media …See details»
Late stage brain tumor clinical trial. AA3 — Orbus Therapeutics
The study enrolled a total of 343 patients and, importantly, it included a large subset (n=194) of grade 3 IDH mutant astrocytoma patients, as defined by World Health Organization (WHO) …See details»
Partnering to develop and commercialize our lead product …
The company’s lead product candidate under active development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent that inhibits tumor growth by preventing cell …See details»